Nur Izzatul Auni Romli1, Kumutha Malar Vellasamy1, Anis Rageh Mohammed Al-Maleki1, Kartini Abdul Jabar1*
1. Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, 50603 Kuala Lumpur, Malaysia
*Corresponding author: Kartini Abdul Jabar.
ABSTRACT
INTRODUCTION: Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic pathogen associated with increased morbidity and mortality, particularly in immunocompromised patients and those with invasive medical devices. Its growing resistance to antibiotics poses a significant global health challenge.
OBJECTIVE(S): To determine the presence of 'silent' carbapenemase and beta-lactamase genes in P. aeruginosa clinical isolates from laboratory stocks.
MATERIALS & METHODS: Thirty P. aeruginosa clinical isolates were selected from laboratory stock. DNA was extracted using the boiling method and subjected to conventional PCR to detect 12 antibiotic-inactivating enzyme genes, comprising of 7 beta-lactamase genes (TEM, OXA, CTXM, GES, VEB, DIM, and AmpC) and 5 carbapenemase genes (IMP-A, IMP-B, IMP-C, NDM, and VIM). Antimicrobial susceptibility testing (AST) was performed using the VITEK® 2 (bioMérieux, France) automated system against ceftazidime, cefepime, ciprofloxacin, piperacillin-tazobactam, imipenem, and meropenem. Data were interpreted according to CLSI M100, 34th edition.
RESULTS: Of the 12 genes screened, 11 are acquired resistance genes, while AmpC is intrinsic. AmpC was detected in 86.6% of the isolates, while the other beta-lactamase genes (TEM, OXA, CTXM, GES, VEB, and DIM) were not detected in any of the isolates. For carbapenemase genes, IMP-A, IMP-B, and IMP-C were detected in 33.3%, 76.6%, and 10% of the isolates, respectively. Nevertheless, all isolates remained susceptible to imipenem and meropenem. Resistance was observed in 16.7% of isolates for piperacillin-tazobactam, 10% each for ceftazidime and cefepime, and 6.7% for ciprofloxacin.
CONCLUSION: Despite harbouring resistance genes, most isolates remained phenotypically susceptible, suggesting low or absent gene expression. This was particularly evident for carbapenems, where all isolates were susceptible despite 76.7% of isolates harbouring at least one carbapenemase gene. Continued surveillance is essential to detect emerging resistance and inform antimicrobial stewardship efforts.
KEYWORDS: Pseudomonas aeruginosa, Antimicrobial Resistance, Resistance Genes


